Purchase Order HHSN268200700158P
- Not listed
- This federal contract award to Miltenyi Biotec, Inc. is for the supply of laboratory equipment, including flow cytometers, cell sorters, tissue dissociators, and associated reagents and consumables. The $4,881 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
- This federal contract award, valued at $110,254.00, was issued by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Miltenyi Biotec, Inc., a global biotechnology company. The contract is for the delivery and installation of specialized laboratory equipment, reagents, and consumables used in cell isolation, analysis, and processing. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, including the...
- The federal contract award is for a service agreement with Miltenyi Biotec, Inc., a global biotechnology company that specializes in scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract, valued at $10,180.00, is a firm fixed-price purchase order awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the National Institutes of Health (NIH). The contract runs from August 1, 2024, to...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company, to provide specialized scientific instruments, reagents, and services to support the NIH's biomedical research and cell therapy development programs. The $5,420 firm fixed-price purchase order has a period of performance through September 2023. Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical...
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $5,550.00, is for the delivery and installation of specialized laboratory equipment and related reagents and consumables. This includes flow cytometers, cell sorters, tissue dissociators, and automated cell separation systems, as well as proprietary reagents and...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award...
- This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of goods. The $211,830 contract is for the provision of Miltenyi's biotechnology products and services to support biomedical research and cell and gene therapy, including instruments, reagents, kits, and antibodies. The award does not have a set-aside...
This federal contract was awarded by an unspecified government agency to Miltenyi Biotec, Inc., a global biotechnology company. The $44,402.00 contract is for the provision of laboratory equipment and supplies. It is not designated as a set-aside contract. Miltenyi Biotec specializes in scientific instruments, bioreagents, cell separation technology, flow cytometry platforms, and services supporting cell and gene therapy manufacturing. The company has served as a prime contractor on numerous contracts with agencies including the National Institutes of Health, Department of Veterans Affairs, and Centers for Disease Control and Prevention. This particular award is associated with a $1.9 million single award indefinite delivery vehicle issued by the NIH Clinical Center in June 2023. Under this vehicle, Miltenyi will provide proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options extending to 2027. These FDA-approved products are required by the NIH's Cell Processing Section to manufacture cell therapy products for clinical trials in an FDA-regulated environment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.4k | 9/21/07 |